Overview

Breast density affects mammographic sensitivity and cancer detection rates. Dense tissue can mask lesions leading to supplemental imaging considerations. Personalized screening strategies account for density and risk factors.

Supplemental Modalities

Ultrasound and MRI are options for supplemental screening in dense breasts. Each modality has benefits and limitations including false positive rates and cost. Shared decision making guides modality selection.

Risk Communication

Clear communication about density and screening implications supports informed choices. Reporting systems may include density information for clinicians and patients. Education reduces confusion and improves adherence to recommendations.

Research Needs

Studies evaluate outcomes of density based supplemental screening strategies. Evidence on mortality benefit and cost effectiveness informs guidelines. Ongoing research refines risk stratification and screening algorithms.